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Abstract   
Introduction: Despite the importance of thyroid hormones in reproduction, there are only a 
few studies that focus on male infertility. The objective of this study was to evaluate semen 
parameters in patients with hypothyroidism or hyperthyroidism. 
Materials and methods: Totally, 28 patients with thyroid disorders were evaluated for the 
semen parameters. Serum TSH and T4 concentrations were measured by ELISA. Complete 
semen analyses were performed based on WHO. 
Results: Pathozoospermia was seen in 32.14% of our patients. Two hyperthyroid patients and 
seven hypothyroid patients suffered sperm defects. None of pathozoospermia patients showed 
an alone sperm defects. Sperm multiple anomalies were our main findings. 
Conclusion: It seems that sperm characterizes strongly were affected. Although, we have a 
limited sample size, but sperm multiple abnormalities made our interest findings.  
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Introduction  
Fertility and childbearing may be one of the 
desired goals in the couples' life. 
Unfortunately, approximately 50 to 80 
million of people suffer from infertility in 
worldwide (1-3). Male factor infertility is 
considered responsible for 30 % of these 
cases. However, in approximately 15 % of 
cases, the etiology remains unclear (4). This 
complex procedure is influenced by varying 
factors such as hormones. It is now well-
established that endocrine system has an 
important physiological role in maintaining 
and regulation of sexual development and 
reproductive function (5-7). 
There are many studies that target thyroid 
hormones level variations in infertile 
couples, commonly female partner. The 
objective of this study was to compare 
semen parameters in hypo/hyper thyroid 
patients without any infertility complaint. 
Similar study, to the best of our knowledge, 
has not published from Iran previously. 
Material and methods 
Subject: This single center study was 
approved by the Research committees of 
AJA University of Medical Sciences in 
Tehran, Iran (code: 85/90/400) and 
informed consent was obtained from all 
patients. In a during 20 months, those 
patients, who had been untreated for their 
thyroid disease, were introduced to the 
research team by thyroid endocrinology 
clinic,  Emam Reza Hospital, Tehran , Iran. 
Subjects were excluded if they were /are 
taking medications or any drug known to 
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potentially interfere with thyroid function 
or semen characteristics, also had 
experienced prior vasectomy and 
cryptorchidism.  
Serum assay: Serum TSH and T4 
concentrations were measured by ELISA 
(BioVendor, Heidelberg, Germany). This 
hormone assay was performed according to 
the DIAPLUS kit (Toronto, Canada) 
protocol. The reference ranges of TSH and 
T4 were 0.39-5.95 μg/dl and 4.4-10.8 μg/dl, 
respectively. Experimental bias was 
diminished by using a double-blind 
procedure. 
Semen analysis: According to WHO 
guidelines of 2010, semen samples were 
collected by masturbation after a 4 day 
sexual abstinence (8). Following 
liquefaction for a period of 15 to 30 minutes 
at room temperature, complete semen 
analyses were performed. As soon as 
possible after liquefaction, each sample's 
motility was evaluated at room temperature 
with a heated microscope stage that was 
standardized for our laboratory. Sperm 
motility was classified as follows: 
Progressive (class A+B), Non-progressive 
(class C) and Immotile (class D). The 
Sperm count assessment was performed 
with usual manner wet preparation. Using 
haemocytometer chamber, at least 200 
spermatozoa were counted. Concentration 
in spermatozoa per ml was calculated. 
Sperm morphology was evaluated using the 
Diff-Quick staining method. Briefly, two 
slides were prepared from each fresh semen 
sample. After air-drying, fixing and 
staining, the slides were examined with 
bright field optics at ×1000 magnification 
with oil immersion. In this assessment 
approximately 200 spermatozoa were 
counted in five squares.  
Statistical analysis 
All patients were divided into 2 subgroups 
according to laboratory hallmarks: 
hypothyroids and hyperthyroid. Then 
statistical analyses were carried out using 
SPSS (v. 15.0) and a value of P<0.05 was 
considered significant. Continuous 
variables were summarized as mean and 
standard deviation and categorical variables 
as absolute and relative frequencies. 
Results 
The participants included 28 individuals 
ranging in age from 24 to 38 years (mean 
±SD:  29.5±3.8). A total of 6 (21.42%) of 
28 patients had considered as 
hyperthyroidism, which was identified in 
serum levels of TSH and T4. The average 
serum levels of TSH and T4 were found 
0.8±0.06 μg/dl and 14.1±1.5μg/dl (mean 
±SD), respectively. Our results also showed 
that other participants (n= 22) may be in 
place Hypothyroidism for their TSH and T4 
serum levels (mean ±SD: 9.6 ±2.3 μg/dl and 
3.4±0.8 μg/dl, respectively). 
Normozoospermia was observed in 68.75% 
(n=19) of our patients (four in the 
Hyperthyroidism group vs. fifteen in 
Hypothyroidism group). Also, 
pathozoospermia was seen in 32.14 % 
(n=9) of our participants (Two in the 
hyperthyroidism group vs. seven in 
hypothyroidism group).  
Five patients in this study suffered from 
asthenospermia; 1 patients of 
hyperthyroidism group and 4 patients of 
hypothyroidism group. No significant 
difference was observed among groups (P = 
0.571). Our results showed that six patients 
have morphologically abnormal sperm cells 
(one in the Hyperthyroidism group vs. five 
in Hypothyroidism group). There was no 
significant difference in sperm morphology 
(P = 0.657) between two groups. Also, no 
significant difference (P = 0.515) was also 
seen to exist between total sperm count in 
both groups (18.5±3.9 × 106 per ml in 
Hyperthyroidism group vs. 20.8±4.2 × 106 








































The interesting finding of the present study 
is teratospermia. Hyperthyroidism group 
showed 16.7% teratospermia and 
hypothyroid patients demonstrated totally 
22.7% teratospermia. Based on Karras and 
Pontikides review article, there is a study 
that reports sperm morphology defects in 
non-euthyroidism men: De La Balze et al. 
(5). We observed teratospermia not only in 
hypothyroids group, but also in 
hyperthyroid ones. Recently Krassas et al. 
showed morphology was affected at 
significant levels in hypothyroid patients 
(9). Several studies support an association 
between thyroid hormones and Sertoli cells 
functions. These studies have demonstrated 
that thyroid hormones receptors exist in 
proliferating Sertoli cells. At this point 
Sertoli cells are introduced as a major target 
for thyroid hormone. Their effects are 
probably mediated through the duration of 
Sertoli cell division and involved in the 
maturational changes (10). Comparison of 
studies: Sperm motility is probably a 
main change in hyperthyroid patients. 
Abalovich et al. found that 18 patients 
(n=21, 85.7%) had a motility problem 
(astenospermia).  The same result was 
obtained by Krassas et al. In their study all 
patients (n=23) showed astenospermia 
without any other sperm defects (7). But 
our results were different. We observed 
astenospermia associated with teratospemia 
with one of hyperthyroid patients. In 
hypothyroid group five patients (22.7%) 
indicated astenospermia that in comparison 
with Wortsman et al. is much lower. 
Wortsman et al. found astenospermia in 
87.5% of their hypothyroid patients (n=8) 
that was associated with 
oligoteratospermia. A remarkable point in 
their study could be age. Age could be a 
remarkable point in these studies. The 
participants age ranged varied from 17 to 77 
years: De La Balzed et al. (17-59) y; 
Wortsman et al. (37-77) y and present study 
(24-38) y. This viewpoint is consistent with 
studies which indicated a significant age- 
dependent reduction in sperm quality (11-
13). Although there are few studies that 
investigated thyroid hormones alterations 
in the male reproductive system and semen 
quality, but animal models helped well 
establish the testicular changes' 
mechanism. In Wistar rat have been 
demonstrated that hypothyroidism reduces 
seminiferous tubules and lumen diameters 
significantly (14). Also, other studies 
indicated that Sertoli cell differentiation 
postponed in hypothyroid rats and these rats 
showed a prolongation of Sertoli cell 
proliferation time. It is notable that transient 
hypothyroidism associated with less 
damage to the testes (15). Furthermore, 
sperm count deficiency was emerged as a 
common defect in our groups. In 
hypothyroid group, oligospermia was 
observed in seven patients that was 
associated with astenospermia  and 
teratospermia and teratoastenospermia. 
Only two patients of hyperthyroids group 
showed pathozoospermia in the present 
study that was not their single sperm 
defects. This finding is almost near to Clyde 
et al. (1976) and Kidd et al. (1979) reports 
in hyperthyroid man, 3 and 5 patients 
respectively. But there is a main difference; 
we observed oligospermia was associated 
with other sperm defects and was not seen 
as an alone defects in our patients. 
Moreover, multiple abnormalities made our 
main finding in this study. Although there 
are few published studies that report semen 
analysis in hypo/hyper thyroid patients, but 
there is no study that report multiple 
anomalies. In our study, none of 
hypothyroid affected men demonstrated 
only a single defect ((n= 2: O+T), (n=3: 
O+A), and (n=2: O+A+T)). And we 
observed no alone form of 
pathozoospermia in hyperthyroid affected 
men ((n= 1: O+T), (n=1: A+O)). It seems 
there is not same published report from 
Iranian population, therefore it plays a role 
as a pilot study. Our study lacked a control 
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number of patients in a different age range 
that make it difficult to draw definitive 
conclusion. This said, we need to perform 
further studies on larger appropriate case 
and control Iranian populations to confirm 
these observations.  
Conclusion 
Scientific investigations support the impact 
of thyroid hormones on reproductive. These 
findings demonstrated that thyroid 
hormones' dysfunction associated with 
sperm defects. It seems that these effects 
are strongly dependent upon the timing 
of onset and severity. Therefore, more 
precision is suggested in work up 
assessment in the clinic. 
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